US Stock MarketDetailed Quotes

Coeptis Therapeutics (COEP)

Watchlist
  • 16.400
  • 0.0000.00%
Close Apr 24 16:00 ET
102.06MMarket Cap-5.84P/E (TTM)

Coeptis Therapeutics (COEP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.38%-8.6M
-17.50%-1.69M
-13.72%-2.15M
-69.05%-2.4M
-24.38%-2.37M
8.15%-6.65M
15.19%-1.44M
3.36%-1.89M
25.50%-1.42M
-12.94%-1.9M
Net income from continuing operations
-12.87%-12.28M
46.11%-1.62M
-58.50%-2.9M
-42.80%-4.33M
-13.98%-3.42M
48.85%-10.88M
19.81%-3.01M
71.20%-1.83M
5.22%-3.04M
62.28%-3M
Operating gains losses
-178.72%-432.8K
-151.61%-400.91K
122.12%77.31K
-326.04%-337.36K
953.79%228.18K
-73.12%549.81K
119.41%776.79K
68.06%-349.5K
-47.91%149.25K
-101.07%-26.73K
Depreciation and amortization
17.71%1.22M
17.70%306.01K
9.90%305.77K
26.73%305.53K
17.72%305.3K
0.27%1.04M
2.10%259.98K
-0.83%278.23K
-3.69%241.08K
3.61%259.34K
Other non cash items
83.24%3.04M
-171.49%-202.41K
226.17%161.45K
362.31%2.94M
-79.14%144.33K
-81.01%1.66M
-32.85%283.12K
-98.98%49.5K
81.08%635.6K
-77.81%691.75K
Change In working capital
-1,065.60%-1.46M
347.90%109.8K
-317.71%-579.88K
-3,767.95%-769.22K
-383.95%-220.76K
-107.25%-125.26K
-104.90%-44.29K
-157.66%-138.83K
-106.66%-19.89K
-72.69%77.74K
-Change in receivables
96.87%-7.35K
195.23%78.69K
---56.04K
63.64%-30K
--0
-659.61%-234.74K
-116.64%-82.64K
--0
---82.5K
-961.97%-69.6K
-Change in prepaid assets
-299.67%-473.5K
-51.54%-417.26K
58.33%103K
-619.51%-232.14K
54.65%72.9K
-230.54%-118.47K
-2,062.45%-275.35K
55.47%65.06K
215.33%44.69K
127.63%47.14K
-Change in payables and accrued expense
-2,751.38%-821.9K
-20.00%70.87K
-88.43%-331.16K
-339.89%-412.51K
-177.15%-149.11K
-98.17%31K
-90.44%88.59K
-176.34%-175.74K
-39.59%171.96K
-121.01%-53.8K
-Change in other current liabilities
-179.87%-157.31K
-104.88%-10.99K
----
----
-193.86%-144.55K
749.50%196.95K
41,819.93%225.11K
----
----
--154.01K
-Change in other working capital
----
----
---149.37K
----
----
----
----
----
68.60%-65
121.63%45
Cash from discontinued investing activities
Operating cash flow
-29.38%-8.6M
-17.50%-1.69M
-13.72%-2.15M
-69.05%-2.4M
-24.38%-2.37M
8.15%-6.65M
15.19%-1.44M
3.36%-1.89M
25.50%-1.42M
-12.94%-1.9M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
-100K
Net other investing changes
----
----
----
----
----
----
----
--0
--0
---100K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--100K
--0
--0
---100K
Financing cash flow
Cash flow from continuing financing activities
140.58%13.74M
235.22%2.45M
243.32%5.06M
-93.56%125.1K
290.51%6.1M
16.18%5.71M
-58.21%731.97K
755.77%1.47M
-42.68%1.94M
1.56M
Net issuance payments of debt
-35.68%771.25K
--0
--0
--0
-27.41%771.25K
308.53%1.2M
68.27%-63.47K
--0
-94.10%200K
--1.06M
Net common stock issuance
7,417.30%7.52M
2,353.48%2.45M
----
----
--0
-98.11%100K
-94.29%100K
----
----
--500K
Net preferred stock issuance
39.37%5.46M
--0
----
----
--5.33M
--3.91M
--695.44K
----
----
--0
Proceeds from stock option exercised by employees
-99.82%900
--250
--150
-99.98%100
--400
150.00%500K
--0
--0
--500K
--0
Cash from discontinued financing activities
Financing cash flow
140.58%13.74M
235.22%2.45M
243.32%5.06M
-93.56%125.1K
290.51%6.1M
16.18%5.71M
-58.21%731.97K
755.77%1.47M
-42.68%1.94M
--1.56M
Net cash flow
Beginning cash position
-63.73%532.89K
331.53%4.91M
28.40%2M
314.71%4.27M
-63.73%532.89K
-61.25%1.47M
-19.42%1.14M
-52.08%1.56M
-51.15%1.03M
-61.25%1.47M
Current changes in cash
649.15%5.14M
226.67%765.82K
797.22%2.91M
-532.01%-2.27M
949.19%3.74M
59.68%-936.25K
-1,149.16%-604.57K
77.22%-417.62K
-53.79%525.83K
73.89%-439.89K
End cash Position
964.83%5.67M
964.83%5.67M
331.53%4.91M
28.40%2M
314.71%4.27M
-63.73%532.89K
-63.73%532.89K
-19.42%1.14M
-52.08%1.56M
-51.15%1.03M
Free cash flow
-29.38%-8.6M
-17.50%-1.69M
-13.72%-2.15M
-69.05%-2.4M
-24.38%-2.37M
8.15%-6.65M
15.19%-1.44M
3.36%-1.89M
25.50%-1.42M
-12.94%-1.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.38%-8.6M-17.50%-1.69M-13.72%-2.15M-69.05%-2.4M-24.38%-2.37M8.15%-6.65M15.19%-1.44M3.36%-1.89M25.50%-1.42M-12.94%-1.9M
Net income from continuing operations -12.87%-12.28M46.11%-1.62M-58.50%-2.9M-42.80%-4.33M-13.98%-3.42M48.85%-10.88M19.81%-3.01M71.20%-1.83M5.22%-3.04M62.28%-3M
Operating gains losses -178.72%-432.8K-151.61%-400.91K122.12%77.31K-326.04%-337.36K953.79%228.18K-73.12%549.81K119.41%776.79K68.06%-349.5K-47.91%149.25K-101.07%-26.73K
Depreciation and amortization 17.71%1.22M17.70%306.01K9.90%305.77K26.73%305.53K17.72%305.3K0.27%1.04M2.10%259.98K-0.83%278.23K-3.69%241.08K3.61%259.34K
Other non cash items 83.24%3.04M-171.49%-202.41K226.17%161.45K362.31%2.94M-79.14%144.33K-81.01%1.66M-32.85%283.12K-98.98%49.5K81.08%635.6K-77.81%691.75K
Change In working capital -1,065.60%-1.46M347.90%109.8K-317.71%-579.88K-3,767.95%-769.22K-383.95%-220.76K-107.25%-125.26K-104.90%-44.29K-157.66%-138.83K-106.66%-19.89K-72.69%77.74K
-Change in receivables 96.87%-7.35K195.23%78.69K---56.04K63.64%-30K--0-659.61%-234.74K-116.64%-82.64K--0---82.5K-961.97%-69.6K
-Change in prepaid assets -299.67%-473.5K-51.54%-417.26K58.33%103K-619.51%-232.14K54.65%72.9K-230.54%-118.47K-2,062.45%-275.35K55.47%65.06K215.33%44.69K127.63%47.14K
-Change in payables and accrued expense -2,751.38%-821.9K-20.00%70.87K-88.43%-331.16K-339.89%-412.51K-177.15%-149.11K-98.17%31K-90.44%88.59K-176.34%-175.74K-39.59%171.96K-121.01%-53.8K
-Change in other current liabilities -179.87%-157.31K-104.88%-10.99K---------193.86%-144.55K749.50%196.95K41,819.93%225.11K----------154.01K
-Change in other working capital -----------149.37K--------------------68.60%-65121.63%45
Cash from discontinued investing activities
Operating cash flow -29.38%-8.6M-17.50%-1.69M-13.72%-2.15M-69.05%-2.4M-24.38%-2.37M8.15%-6.65M15.19%-1.44M3.36%-1.89M25.50%-1.42M-12.94%-1.9M
Investing cash flow
Cash flow from continuing investing activities 00000-100K
Net other investing changes ------------------------------0--0---100K
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--100K--0--0---100K
Financing cash flow
Cash flow from continuing financing activities 140.58%13.74M235.22%2.45M243.32%5.06M-93.56%125.1K290.51%6.1M16.18%5.71M-58.21%731.97K755.77%1.47M-42.68%1.94M1.56M
Net issuance payments of debt -35.68%771.25K--0--0--0-27.41%771.25K308.53%1.2M68.27%-63.47K--0-94.10%200K--1.06M
Net common stock issuance 7,417.30%7.52M2,353.48%2.45M----------0-98.11%100K-94.29%100K----------500K
Net preferred stock issuance 39.37%5.46M--0----------5.33M--3.91M--695.44K----------0
Proceeds from stock option exercised by employees -99.82%900--250--150-99.98%100--400150.00%500K--0--0--500K--0
Cash from discontinued financing activities
Financing cash flow 140.58%13.74M235.22%2.45M243.32%5.06M-93.56%125.1K290.51%6.1M16.18%5.71M-58.21%731.97K755.77%1.47M-42.68%1.94M--1.56M
Net cash flow
Beginning cash position -63.73%532.89K331.53%4.91M28.40%2M314.71%4.27M-63.73%532.89K-61.25%1.47M-19.42%1.14M-52.08%1.56M-51.15%1.03M-61.25%1.47M
Current changes in cash 649.15%5.14M226.67%765.82K797.22%2.91M-532.01%-2.27M949.19%3.74M59.68%-936.25K-1,149.16%-604.57K77.22%-417.62K-53.79%525.83K73.89%-439.89K
End cash Position 964.83%5.67M964.83%5.67M331.53%4.91M28.40%2M314.71%4.27M-63.73%532.89K-63.73%532.89K-19.42%1.14M-52.08%1.56M-51.15%1.03M
Free cash flow -29.38%-8.6M-17.50%-1.69M-13.72%-2.15M-69.05%-2.4M-24.38%-2.37M8.15%-6.65M15.19%-1.44M3.36%-1.89M25.50%-1.42M-12.94%-1.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More